MusclePharm
Financial ratios & Valuation

Historical Multiples (2012 – 2021)

2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 TTM Median
Valuation Ratios
Price/Earnings ratio
-0.41-3.36-0.30-0.09-1.46-0.48-0.53-0.414.91-1.21-0.00-1.46
Price/Sales ratio
0.110.530.020.030.030.050.060.090.240.310.000.05
Price/Book Value ratio
-0.793.020.17-0.51-1.04-0.42-0.20-0.27-0.64-0.48-0.00-1.04
Price/Cash Flow ratio
-11.18-5.98-1.010.94-0.33-1.022.88-1.19-18.02-1.94-0.00-0.33
Price/Free Cash Flow ratio
-4.81-5.01-0.481.78-0.32-1.023.08-1.19-17.94-1.94-0.00-0.32
Price/Earnings Growth ratio
-0.00-0.030.00-0.000.01-0.000.05-0.01-0.040.000.000.00
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
21.36%29.93%31.57%34.11%33.56%29.80%20.87%10.90%30.42%10.73%6.37%29.80%
Operating Profit Margin
-13.02%-15.16%-7.66%-30.54%-1.14%-7.41%-7.77%-18.93%7.54%-14.78%-23.31%-7.41%
Pretax Profit Margin
-28.26%-15.87%-7.77%-31.01%-2.38%-10.60%-12.09%-23.64%4.91%-25.72%-38.52%-10.60%
Net Profit Margin
-28.26%-15.97%-7.79%-31.07%-2.62%-10.74%-12.20%-23.75%4.94%-25.74%-38.50%-10.74%
Effective Tax Rate
N/A-0.65%-0.23%-0.20%-10.06%-1.31%-0.93%-0.45%-0.60%-0.06%-0.04%-10.06%
Return on Assets
-280.08%-33.96%-20.84%-81.30%-10.19%-32.43%-43.71%-130.17%24.49%-114.91%-160.81%-32.43%
Return On Equity
194.22%-89.78%-59.16%515.07%71.25%87.54%38.14%67.71%-13.04%40.01%60.98%87.54%
Return on Capital Employed
89.56%-84.99%-57.79%1453.49%34.95%-141.68%24.51%55.86%-25.57%24.77%32.22%-141.68%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A0.24N/A
Quick Ratio
0.190.590.590.510.520.840.170.170.330.220.200.84
Cash ratio
N/A0.160.020.100.120.210.040.030.060.020.010.21
Days of Sales Outstanding
17.9745.2334.2448.1336.7859.5525.9822.0242.4146.5967.6936.78
Days of Inventory outstanding
1.7874.1063.3541.6635.5233.0071.5124.278.4014.957.5933.00
Operating Cycle
19.76119.3497.6089.7972.3192.5597.5046.2950.8161.5424.2992.55
Days of Payables Outstanding
N/AN/A83.48131.6539.9159.76129.81134.61119.83146.91147.1239.91
Cash Conversion Cycle
19.76119.3414.12-41.8632.4032.79-32.31-88.32-69.02-85.36-77.5632.79
Debt Ratios
Debt Ratio
2.440.620.120.140.480.58N/A0.730.850.954.170.48
Debt Equity Ratio
-1.691.640.34-0.88-3.37-1.56N/A-0.38-0.45-0.33-1.31-3.37
Long-term Debt to Capitalization
-0.00N/AN/A-1.44N/A4.03N/A-0.02-0.01N/AN/A4.03
Total Debt to Capitalization
N/AN/A0.25-8.021.422.75N/A-0.61-0.82-0.49N/A2.75
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-2.08N/A
Cash Flow to Debt Ratio
-154.23N/A-0.510.61-0.91-0.26N/A-0.61-0.07-0.75N/A-0.91
Company Equity Multiplier
-0.692.642.83-6.33-6.98-2.69-0.87-0.52-0.53-0.34-0.31-6.98
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-0.01-0.08-0.020.03-0.11-0.050.02-0.08-0.01-0.16-0.23-0.05
Free Cash Flow / Operating Cash Flow Ratio
2.321.192.110.521.031.000.931.001.001.000.991.00
Cash Flow Coverage Ratio
N/AN/A-0.510.61-0.91-0.26N/A-0.61-0.07-0.75N/A-0.91
Short Term Coverage Ratio
N/AN/A-0.511.83-0.91-1.71N/A-0.65-0.08-0.75-0.51-0.91
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A